{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:14Z","timestamp":1791821954883,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2022XY024"],"award-info":[{"award-number":["BMU2022XY024"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3403100"],"award-info":[{"award-number":["2023YFC3403100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20384"],"award-info":[{"award-number":["U22A20384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973259"],"award-info":[{"award-number":["81973259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007928","name":"Ningbo Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2022Z142"],"award-info":[{"award-number":["2022Z142"]}],"id":[{"id":"10.13039\/501100007928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L242056"],"award-info":[{"award-number":["L242056"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114378","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:39:55Z","timestamp":1762119595000},"page":"114378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion"],"prefix":"10.1016","volume":"388","author":[{"given":"Ning","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2025.114378_bb0005","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","article-title":"The global impact of hepatic fibrosis and end-stage liver disease","volume":"12","author":"Lim","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114378_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114378_bb0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114378_bb0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-0716-1382-5_23","article-title":"Mouse models of liver fibrosis","volume":"2299","author":"Ravichandra","year":"2021","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114378_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114378_bb0030","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1038\/ncomms13498","article-title":"CUG-binding protein 1 regulates HSC activation and liver fibrogenesis","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.jconrel.2025.114378_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012572","article-title":"The molecular mechanisms of liver fibrosis and its potential therapy in application","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114378_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114378_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114378_bb0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114378_bb0055","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28921","article-title":"The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice","volume":"65","author":"Maiers","year":"2017","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114378_bb0060","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/14737159.2020.1814746","article-title":"Advances in the clinical use of collagen as biomarker of liver fibrosis","volume":"20","author":"Meurer","year":"2020","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03759-z","article-title":"Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management","volume":"20","author":"Abd El-Fattah","year":"2022","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/14728222.2021.1861249","article-title":"HSP47: a potential target for fibrotic diseases and implications for therapy","volume":"25","author":"Bellaye","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0968-0004(06)80023-X","article-title":"Hsp47: a collagen-specific molecular chaperone","volume":"21","author":"Nagata","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2025.114378_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2025.114378_bb0085","first-page":"1163","article-title":"Natural endogenous material-based vehicles for delivery of macromolecular drugs","volume":"22","author":"Lu","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114378_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154\u2013155","author":"Bottger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114378_bb0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114378_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/nano12101683","article-title":"Fish oil Nanoemulsion supplementation attenuates bleomycin-induced pulmonary fibrosis BALB\/c mice","volume":"12","author":"Galdino de Souza","year":"2022","journal-title":"Nanomaterials (Basel)"},{"issue":"19","key":"10.1016\/j.jconrel.2025.114378_bb0105","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114378_bb0110","doi-asserted-by":"crossref","first-page":"44545","DOI":"10.1038\/srep44545","article-title":"Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model","volume":"7","author":"Ozturk Akcora","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1165\/rcmb.2016-0217OC","article-title":"A novel antifibrotic mechanism of Nintedanib and pirfenidone. inhibition of collagen fibril assembly","volume":"57","author":"Knuppel","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114378_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1080\/17425247.2021.1985460","article-title":"Advances and challenges in nintedanib drug delivery","volume":"18","author":"Velagacherla","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"13","key":"10.1016\/j.jconrel.2025.114378_bb0125","doi-asserted-by":"crossref","first-page":"14839","DOI":"10.1021\/acsami.9b22781","article-title":"Microfluidic-based holonomic constraints of siRNA in the kernel of lipid\/polymer hybrid Nanoassemblies for improving stable and safe in vivo delivery","volume":"12","author":"Wei","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114378_bb0135","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.12688\/f1000research.138786.1","article-title":"A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers","volume":"12","author":"Velagacherla","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.jconrel.2025.114378_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123644","article-title":"Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models","volume":"649","author":"Kaur","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114378_bb0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/IJN.S228715","article-title":"Preparation, characterization, and pharmacokinetic study of a novel long-acting targeted paclitaxel liposome with antitumor activity","volume":"15","author":"Han","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114378_bb0150","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1080\/1061186X.2025.2484773","article-title":"Methodological advances in liposomal encapsulation efficiency determination: systematic review and analysis","volume":"33","author":"Wang","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2025.114378_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fbioe.2015.00014","article-title":"Targeting cell cycle proteins in breast cancer cells with siRNA by using lipid-substituted polyethylenimines","volume":"3","author":"Parmar","year":"2015","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114378_bb0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2017.11.019","article-title":"Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells","volume":"269","author":"Joris","year":"2018","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114378_bb0165","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1021\/acsnano.0c00666","article-title":"Cationic amphiphilic drugs boost the lysosomal escape of small nucleic acid therapeutics in a nanocarrier-dependent manner","volume":"14","author":"Van de Vyver","year":"2020","journal-title":"ACS Nano"},{"issue":"46","key":"10.1016\/j.jconrel.2025.114378_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303614","article-title":"Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114378_bb0175","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jconrel.2021.10.012","article-title":"Enhanced cancer therapeutic efficiency of NO combined with siRNA by caspase-3 responsive polymers","volume":"339","author":"Yan","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0180","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-022-29186-8","article-title":"Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114378_bb0185","article-title":"Nanomedicines reprogram synovial macrophages by scavenging nitric oxide and silencing CA9 in progressive osteoarthritis","volume":"10","author":"Yan","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114378_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124799","article-title":"Effects of nanoparticle size, shape, and zeta potential on drug delivery","volume":"666","author":"Ozturk","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114378_bb0195","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41401-020-0381-y","article-title":"Nintedanib inhibits keloid fibroblast functions by blocking the phosphorylation of multiple kinases and enhancing receptor internalization","volume":"41","author":"Zhou","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s42003-021-01728-8","article-title":"A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery","volume":"4","author":"Munson","year":"2021","journal-title":"Commun. Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114378_bb0205","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0210","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s41467-020-15300-1","article-title":"Imaging small molecule-induced endosomal escape of siRNA","volume":"11","author":"Du Rietz","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114378_bb0215","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jcb.30311","article-title":"Rhein induces changes in the lysosomal compartment of HeLa cells","volume":"123","author":"Trybus","year":"2022","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0220","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-023-38128-x","article-title":"Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock factor 1 modulation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-017-0592-3","article-title":"Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer","volume":"36","author":"Englinger","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114378_bb0230","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2017.04.016","article-title":"pH-dependent solubility and permeability profiles: a useful tool for prediction of oral bioavailability","volume":"105","author":"Sieger","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114378_bb0235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/jm501562a","article-title":"Nintedanib: from discovery to the clinic","volume":"58","author":"Roth","year":"2015","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114378_bb0240","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00726-017-2490-6","article-title":"Roles of dietary glycine, proline, and hydroxyproline in collagen synthesis and animal growth","volume":"50","author":"Li","year":"2018","journal-title":"Amino Acids"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114378_bb0250","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","article-title":"Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114378_bb0255","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/1061186X.2022.2044485","article-title":"Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review","volume":"30","author":"Zhou","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2025.114378_bb0260","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114378_bb0265","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbadis.2013.02.019","article-title":"Origins and functions of liver myofibroblasts","volume":"1832","author":"Lemoinne","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114378_bb0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.201108078","article-title":"FAK promotes recruitment of Talin to nascent adhesions to control cell motility","volume":"196","author":"Lawson","year":"2012","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114378_bb0275","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12951-024-02721-z","article-title":"Nebulized milk exosomes loaded with siTGF-beta1 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability","volume":"22","author":"Qiu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114378_bb0280","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/HEP.0000000000000319","article-title":"Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-beta\/SMAD signaling","volume":"78","author":"Song","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2025.114378_bb0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpb.2022.02.009","article-title":"Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-gamma-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis","volume":"172","author":"Togami","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114378_bb0290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","article-title":"In vivo and in vitro models to study liver fibrosis: mechanisms and limitations","volume":"16","author":"Lee","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:52:01Z","timestamp":1780822321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S0168365925009927"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114378","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114378"}}